Drug intelligence / Profile preview

azithromycin

Development stage
Approved
Lead developer
PLIVA
Modality
Small Molecules
Administration
Oral, Intravenous, Ophthalmic
01

Overview

Azithromycin is a broad-spectrum macrolide antibiotic used to treat a variety of bacterial infections. It is effective against respiratory tract infections (such as bronchitis and pneumonia), skin and soft tissue infections, ear and sinus infections, sexually transmitted diseases (including chlamydia), and certain enteric infections. It is also used to prevent disseminated Mycobacterium avium complex (MAC) infection in people with HIV. Mechanistically, azithromycin binds to the 23S rRNA of the bacterial 50S ribosomal subunit, inhibiting protein synthesis by blocking the transpeptidation/translocation step and assembly of the ribosomal subunit. This action halts bacterial growth. In addition to its antibacterial effects, azithromycin has immunomodulatory properties that have been explored in chronic respiratory inflammatory diseases. The drug was discovered by Pliva in Yugoslavia (now Croatia) in 1980 and approved for medical use in 1988[1][2][3][4][5][6][8].

Brand names
AzasiteZithromaxZmaxZithromax TRI-PAKZithromax Z-Pak
Other names
Azithromycin 3 Day Dose PackAzithromycin3 Day Dose PackAzithromycin-3 Day Dose PackAzithromycin 5 Day Dose PackAzithromycin5 Day Dose PackAzithromycin-5 Day Dose Pack
02

Targets

Bacterial 50S ribosomal subunit

Beyond the preview

Go deeper on azithromycin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on azithromycin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call